BioCryst Pharmaceuticals
BCRX
#4924
Rank
S$2.46 B
Marketcap
S$9.57
Share price
-1.07%
Change (1 day)
4.46%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2026 (TTM): S-$1.73

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S-$1.74. In 2025 the company made an earnings per share (EPS) of S$1.61 an increase over its 2024 EPS that were of S-$0.55.

EPS history for BioCryst Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$1.73-207.47%
2025S$1.61-390.7%
2024S-$0.55-63.56%
2023S-$1.52-11.28%
2022S-$1.7229.13%
2021S-$1.33-4.63%
2020S-$1.3910.2%
2019S-$1.260%
2018S-$1.2625.64%
2017S-$1.014%
2016S-$0.9727.12%
2015S-$0.76-13.24%
2014S-$0.8823.64%
2013S-$0.71-30.38%
2012S-$1.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
S-$4.00 129.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$3.71-313.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
S-$3.39 94.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
S-$0.26-85.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S-$1.96 12.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$5.61 222.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
S-$0.57-67.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$4.10 135.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$6.50 273.33%๐Ÿ‡บ๐Ÿ‡ธ USA